Key Points
- Director Elisha Finney sold 474 shares at an average price of $1,433.57 on Nov. 10, a $679,512 transaction that reduced her stake by 60.38% to 311 shares (valued about $445,840).
- Q3 results beat expectations with EPS of $11.15 (vs. $10.62) and revenue of $1.03B, and the company set Q4 2025 guidance of 12.680–12.880 EPS and FY2025 guidance of 42.050–42.250 EPS.
- Shares are trading down roughly 2.5%, the company has a market cap of about $28.82B, and analysts' consensus is a "Hold" with an average target price of $1,406.50.
Mettler-Toledo International, Inc. (NYSE:MTD - Get Free Report) Director Elisha Finney sold 474 shares of the firm's stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total transaction of $679,512.18. Following the completion of the transaction, the director directly owned 311 shares of the company's stock, valued at $445,840.27. This represents a 60.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Mettler-Toledo International Trading Down 2.5%
Mettler-Toledo International stock opened at $1,411.00 on Friday. The firm has a market capitalization of $28.82 billion, a P/E ratio of 35.73, a P/E/G ratio of 4.19 and a beta of 1.41. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,471.06. The stock's fifty day simple moving average is $1,332.61 and its 200-day simple moving average is $1,245.99.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $1.03 billion during the quarter, compared to analysts' expectations of $997.36 million. During the same period in the previous year, the firm posted $10.21 EPS. Mettler-Toledo International's revenue for the quarter was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Sell-side analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.
Institutional Trading of Mettler-Toledo International
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in shares of Mettler-Toledo International by 1.3% in the 3rd quarter. Vanguard Group Inc. now owns 2,591,173 shares of the medical instruments supplier's stock valued at $3,180,950,000 after buying an additional 34,466 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in Mettler-Toledo International by 71.3% in the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier's stock valued at $1,062,257,000 after acquiring an additional 376,419 shares in the last quarter. Capital International Investors boosted its stake in Mettler-Toledo International by 1.2% in the third quarter. Capital International Investors now owns 859,559 shares of the medical instruments supplier's stock valued at $1,055,203,000 after acquiring an additional 10,395 shares in the last quarter. Alliancebernstein L.P. grew its holdings in shares of Mettler-Toledo International by 1.1% during the second quarter. Alliancebernstein L.P. now owns 717,449 shares of the medical instruments supplier's stock worth $842,802,000 after purchasing an additional 8,121 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Mettler-Toledo International by 0.6% during the second quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier's stock worth $681,489,000 after purchasing an additional 3,383 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on MTD. Stifel Nicolaus upped their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a "buy" rating in a research note on Monday. Bank of America boosted their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a "neutral" rating in a report on Monday, September 22nd. JPMorgan Chase & Co. raised their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a "neutral" rating in a report on Thursday, October 9th. Wells Fargo & Company lifted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an "equal weight" rating in a research report on Monday. Finally, Evercore ISI boosted their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 7th. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, Mettler-Toledo International has an average rating of "Hold" and a consensus target price of $1,406.50.
Check Out Our Latest Stock Analysis on Mettler-Toledo International
About Mettler-Toledo International
(
Get Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
